Recent advances in the management of gout and hyperuricemia |
| |
| Authors: | Wortmann Robert L |
| |
| Affiliation: | Department of Internal Medicine, University of Oklahoma College of Medicine, Tulsa, Oklahoma 74135, USA. Robert-wortmann@ouhsc.edu |
| |
| Abstract: | PURPOSE OF REVIEW: To review the recent advances in the management of gout and hyperuricemia. RECENT FINDINGS: The first quality indicators for gout management have been proposed. Selective COX II inhibitors, as well as traditional NSAIDs, are effective in acute gout. A new xanthine oxidase inhibitor, febuxostat, and pegylated uricases are in clinical trials. SUMMARY: The therapeutic aims in gout include termination of the acute attack as promptly and gently as possible, prevention of future attacks, prevention or reversal of complications of the, and prevention or reversal of associated features such as obesity, hypertriglyceridemia, hypertension, or alcoholism. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
